LAURA BURCHAM: Open Payments
NPI 1679227193 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,474 in 37 payments from 12 companies in 2025. Trend: 2023 $1,420 · 2024 $1,636 · 2025 $1,474
Food & beverage: $1,440Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $513 |
| GENZYME CORPORATION | 7 | $315 |
| Genentech, Inc. | 1 | $150 |
| Blueprint Medicines Corporation | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $73 |
| Amgen Inc. | 3 | $68 |
| GlaxoSmithKline, LLC. | 4 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $51 |
| Paratek Pharmaceuticals, Inc. | 1 | $28 |
Products named: FASENRA, DUPIXENT, TEZSPIRE, Xolair, AYVAKIT, HYQVIA, NUCALA, NEFFY.
Industry payments across OK — which companies pay providers there.
